Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: August 2008
-
By Kevin E. Noonan — The annual report from the Director of the Administrative Office of the U.S. Courts, James C. Duff, was released last week. Entitled "Judicial Business of the United States Courts," this document (weighing in at 416 pages and containing hundreds of pages of tabulated information) contained a few interesting…
-
The Genetics Policy Institute will be holding the 2008 World Stem Cell Summit on September 22-23 in Madison, WI. The Summit, which is being hosted by the University of Wisconsin Stem Cell & Regenerative Medicine Center and WiCell Research Institute, will bring together researchers, clinicians, business pathfinders, key policy-makers, regulators, advocates, and experts in law…
-
By Christopher P. Singer — In an August 27, 2008 notice, the U.S. Patent and Trademark Office (USPTO) announced that it is changing certain forms to remove language that requests a duplicate copy of the form be submitted for fee processing purposes. Previously, the duplicate copy of forms that contained an authorization to…
-
By Donald Zuhn — On Monday, the American Bar Association (ABA) Standing Committee on Ethics and Professional Responsibility released a statement regarding a new ethics opinion (Formal Opinion 08-451), which concludes that U.S. lawyers can outsource legal and nonlegal work provided that they adhere to ethics rules regarding competence, supervision, protection of confidential…
-
By Kevin E. Noonan — We may have reached the high-water mark on the expansion of the inequitable conduct doctrine. Recent decisions from the Federal Circuit seem to signal a retrenchment in the Court’s treatment of the doctrine, and its willingness to affirm district court judgments finding inequitable conduct, particularly in the context…
-
By Donald Zuhn — Helix BioMedix, Inc. announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,407,940, which is directed to hexapeptides that exhibit antimicrobial activity against infections caused by a variety of pathogens. According to Helix Biomedix’s statement, the ‘940 patent covers a family of hexapeptide antimicrobial agents,…
-
By Donald Zuhn — The U.S. Patent and Trademark Office announced today that U.S. Secretary of Commerce Carlos Gutierrez joined President Bush last week in identifying the winners of the 2007 National Medal of Technology and Innovation. The award, previously known as the National Medal of Technology, is the highest honor that the…
-
By Kevin E. Noonan — The Federal Circuit has been redefining its declaratory judgment jurisdiction jurisprudence ever since the Supreme Court’s Medimmune, Inc. v. Genentech, Inc. decision. These cases have included SanDisk Corp. v. STMicroelectronics, Inc., Teva Pharmaceuticals USA, Inc. v. Novartis Pharmaceuticals Corp., Benitec Australia, Ltd. v. Nucleonics, Inc., Caraco Pharmaceutical Laboratories,…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Wyeth v. Apotex Inc. et al.1:08-cv-22308; filed August 18, 2008 in the Southern District of Florida Infringement of U.S. Patent Nos. 6,274,171…
-
September 11, 2008 – Developments in Pharmaceutical and Biotech Patent Law (Practising Law Institute) – New York, NY September 11-12, 2008 – Current Issues in Complex IP Licensing (Law Seminars International) – Philadelphia, PA September 15-16, 2008 – Biotech Patents*** (American Conference Institute) September 21-23, 2008 – 2008 Annual Meeting (Intellectual Property Owners Association) –…
Patent Docs 